Venetoclax combination therapy for relapsed CLL
Importance of taking into consideration new and traditional treatment options for CLL patients
Overcoming mental health issues for patients with CLL
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.
Long-term follow-up results of the ZUMA-1 trial of anti-CD19 CAR T-cells for non-Hodgkin lymphoma